U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
9708197081The Prevalence of Sympathetic Overactivity in Primary Hypertensive Patients.CompletedNo Results AvailableEssential Hypertensionhttps://ClinicalTrials.gov/show/NCT01295021
9708297082Androgenetic Alopecia in Fabry DiseaseRecruitingNo Results AvailableFabry Diseasehttps://ClinicalTrials.gov/show/NCT01295008
9708397083Effect of Short-term Chinese Tea-flavor Liquor ConsumptionCompletedNo Results AvailableCardiovascular DiseasesDietary Supplement: Tea-flavor Liquor|Dietary Supplement: Guizhou Meijiao Liquorhttps://ClinicalTrials.gov/show/NCT01294995
9708497084Study of AOBO-001 for Overactive Bladder With Urge Urinary Incontinence and FrequencyCompletedNo Results AvailableOveractive BladderDrug: AOBO-001|Drug: AOBO-001|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01294982
9708597085Patient Perception Study for AL-4943ACompletedNo Results AvailableAllergic ConjunctivitisDrug: AL-4943Ahttps://ClinicalTrials.gov/show/NCT01294969
9708697086A Clinical Evaluation of an Investigational Lubricant Eye Gel (FID 115958D)CompletedNo Results AvailableDry EyeOther: Lubricant Eye Drop|Other: Refresh Liquigelhttps://ClinicalTrials.gov/show/NCT01294956
9708797087Evaluating the Effectiveness of the Tongue Cleaner in Critical PatientsCompletedNo Results AvailableOral Infection|Ventilator-associated PneumoniaDevice: Tongue cleanerhttps://ClinicalTrials.gov/show/NCT01294943
9708897088Indicators of Operative and Postoperative Complications in Patients Operated for Hip FractureCompletedNo Results AvailableHip FractureOther: Urine densityhttps://ClinicalTrials.gov/show/NCT01294930
9708997089Comparison of a New Abbott Medical Optics (AMO) Multi-Purpose Solution (MPS) to Existing Contact Lens RegimensCompletedHas ResultsNormal Contact Lens Wearers.Device: Multi-purpose disinfecting solution|Device: Clear Care|Device: Opti-Free RepleniSHhttps://ClinicalTrials.gov/show/NCT01294917
9709097090Mechanisms of Infertility and Hormonal Changes in Patients With Chronic Kidney DiseaseEnrolling by invitationNo Results AvailableInfertilityhttps://ClinicalTrials.gov/show/NCT01294904
9709197091Microvascular and Cardiac Dysfunction in Paroxysmal Nocturnal Hemoglobinuria and Sickle Cell DiseaseCompletedNo Results AvailableRheologic Disease|Sickle Cell Disease|Paroxysmal Nocturnal HemoglobinuriaOther: Imaginghttps://ClinicalTrials.gov/show/NCT01294891
9709297092Omalizumab in Interstitial Cystitis/Bladder Pain SyndromeCompletedNo Results AvailableInterstitial Cystitis|Painful Bladder SyndromeDrug: omalizumabhttps://ClinicalTrials.gov/show/NCT01294878
9709397093Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Late-onset Neonatal SepsisActive, not recruitingNo Results AvailableNeonatal Sepsishttps://ClinicalTrials.gov/show/NCT01294865
9709497094Comparison of Two Strategies for Surfactant Prophylaxis in Premature InfantsRecruitingNo Results AvailablePremature Birth|Premature LungsOther: surfactant prophylaxishttps://ClinicalTrials.gov/show/NCT01294852
9709597095Right Ventricular Outflow Tract StudyActive, not recruitingNo Results AvailableSinus-node DysfunctionDevice: Right ventricular lead locationhttps://ClinicalTrials.gov/show/NCT01294839
9709697096Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal CancerCompletedNo Results AvailableRecurrent Colon Cancer|Recurrent Rectal Cancer|Stage IV Colon Cancer|Stage IV Rectal Cancer|Adenocarcinoma of the Colon|Adenocarcinoma of the RectumDrug: AUY922|Drug: Cetuximabhttps://ClinicalTrials.gov/show/NCT01294826
9709797097Bronchoscopy and Electric Impedance Tomography (EIT) Pilot StudyRecruitingNo Results AvailableElectric Impedance Tomography|Bronchoscopy|Change in Lung Impedance Due to Ventilation|Recruitment|Improvement the Treatment of the PatientDevice: Electrical Impedance Tomography (EIT)https://ClinicalTrials.gov/show/NCT01294813
9709897098A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402)CompletedNo Results AvailableParkinson's DiseaseDrug: Preladenant|Drug: Placebo tablet to match Preladenanthttps://ClinicalTrials.gov/show/NCT01294800
9709997099Effect of QVA149 on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedHas ResultsCOPDDrug: indacaterol and glycopyrronium bromide (QVA149)|Drug: placebo|Drug: tiotropiumhttps://ClinicalTrials.gov/show/NCT01294787
9710097100Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus ErythematosusTerminatedNo Results AvailableSubacute Cutaneous Lupus ErythematosusDrug: KRP203 - 1.2mg|Drug: Placebo to KRP203 - 1.2 mghttps://ClinicalTrials.gov/show/NCT01294774
9710197101Comparing Continuing Tenofovir, Emtricitabine (or Lamivudine) Plus Lopinavir and Switching to Raltegravir Plus DarunavirCompletedNo Results AvailableHIV InfectionsDrug: Raltegravir, Darunavir/rhttps://ClinicalTrials.gov/show/NCT01294761
9710297102Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery DiseaseActive, not recruitingHas ResultsCoronary Artery DiseaseDevice: MiStent DES|Device: Endeavor DEShttps://ClinicalTrials.gov/show/NCT01294748
9710397103Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)CompletedNo Results AvailableRecurrence of Solid Tumor|Glioblastoma Multiforme|MelanomaDrug: MK-4827|Drug: Temozolomidehttps://ClinicalTrials.gov/show/NCT01294735
9710497104A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti‐Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in KoreaCompletedNo Results AvailableRheumatoid Arthritishttps://ClinicalTrials.gov/show/NCT01294722
9710597105A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014)CompletedHas ResultsAngina Pectoris|Coronary Heart Disease|Calcitonin Gene-related Peptide ReceptorDrug: telcagepant|Drug: Placebo to telcagepanthttps://ClinicalTrials.gov/show/NCT01294709
9710697106Survey of Osteoarthritis Real World Therapies (MK-0663-140)CompletedHas ResultsOsteoarthritisDrug: Standard of care for treatment of osteoarthritis (OA) of knee(s)https://ClinicalTrials.gov/show/NCT01294696
9710797107A Study to Evaluate Efficacy and Safety of Extended-Release Niacin (+) Laropiprant (+) Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118)TerminatedNo Results AvailablePrimary Hypercholesterolemia|DyslipidemiaDrug: ER niacin/laropiprant/simvastatin|Drug: ER niacin/laropiprant/simvastatin|Drug: ER niacin/laropiprant|Drug: Simvastatin|Drug: Placebo to match simvastatinhttps://ClinicalTrials.gov/show/NCT01294683
9710897108Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients - RecruitingNo Results AvailableSolid Tumors|Relapsed/Refractory SarcomasDrug: Vorinostat and Etoposidehttps://ClinicalTrials.gov/show/NCT01294670
9710997109Obesity: Cancer Risk Among African AmericansActive, not recruitingNo Results AvailableCancer|ObesityBehavioral: Health Education|Behavioral: MAPShttps://ClinicalTrials.gov/show/NCT01294657
9711097110Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental FatCompletedHas ResultsModerate or Severe Submental FullnessDrug: Deoxycholic acid injection|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01294644

* Görseller ve İçerik tekif hakkına sahip olabilir